The mechanosensilla in spider exoskeleton are innervated by bipolar neurons with their cell bodies close to the cuticle and dendrites attached to it. Numerous efferent fibers synapse with peripheral parts of the mechanosensory neurons, with glial cells surrounding the neurons, and with each other. Most of these efferent fibers are immunoreactive to GABA, and the sensory neurons respond to agonists of ionotropic GABA receptors with a rapid and complete inhibition. In contrast, little is known about metabotropic GABA B receptors that may mediate long term effects. We investigated the distribution of GABA B receptors on spider leg mechanosensilla using specific antibodies against two proteins needed to form functional receptors and an antibody that labels the synaptic vesicles on presynaptic sites. Both anti-GABA B receptor antibodies labeled the distal parts of the sensory cell bodies and dendrites but anti-GABA B R1 immunoreactivity was also found in the axons and proximal parts of the cell bodies and some glial cells. The fine efferent fibers that branch on top of the sensory neurons did not show GABA B receptor immunoreactivity but were densely labeled with anti-synapsin and indicated synaptic vesicles on presynaptic locations to the GABA B receptors. Intracellular recordings from sensory neurons innervating the slit sensilla of the spider legs revealed that application of GABA B receptor agonists attenuated voltage-activated Ca 2+ current and enhanced voltage-activated outward K + current, providing two possible mechanisms for controlling the neurons' excitability. These findings support the hypothesis that GABA B receptors are present in the spider mechanosensilla where their activation may modulate information transmission.
INTRODUCTION
A dense network of fine efferent fibers innervates the peripheral parts of arachnid mechanosensilla (Fabian-Fine et al. 1999a ,b, 2000 Foelix et al. 2002) . In the tropical wandering spider (Cupiennius salei, Keys.) the efferent fibers form synapses with the axons, somata and dendrites of the mechanosensory neurons. In addition, the efferent fibers synapse with each other and with glial cells surrounding the sensory neurons (Fabian-Fine et al. 1999b , 2000 . The majority of efferent neurons are immunoreactive to an antibody against the inhibitory neurotransmitter -aminobutyric acid (GABA) (Fabian-Fine et al. 1999b ) and the sensory neurons are inhibited by agonists of ionotropic GABA receptors (Panek et al. 2002) . The mechanism of inhibition is similar to the presynaptic inhibition that modulates most known mechanoreceptor afferent terminals located in the central nervous system (CNS) (e.g. Nusbaum et al. 1997; Rudomin and Smith 1999; Torkkeli and Panek 2002) .
In addition to relatively fast inhibition via ionotropic receptors, GABA can modulate many signal transduction pathways by activating metabotropic G-protein coupled GABA B receptors that play critical roles in long-term modulation of synaptic transmission (Bowery 1993) . These receptors are common in mammalian brain (Bowery 1993; Balon et al. 2002) and spinal cord (Towers et al. 2000) in both pre-and postsynaptic locations, where they mediate mechanisms that play fundamental roles in long term potentiation, muscle relaxation and nociception (Malcangio and Bowery 1996; Staubli et al. 1999; Bowery et al. 2002) . Presynaptic GABA B receptors are believed to decrease Ca 2+ influx and thus suppress neurotransmitter release, while postsynaptic receptors often decrease neuronal excitability by activating K + currents (Kaupmann et al. 1998; Bowery et al. 2002) . GABA B -receptors also exist in arthropod CNS (e.g. Bai and Sattelle 1995; Mezler et al. 2001) but very little is known about their distribution, mechanisms of action or the types of responses they mediate.
Two different GABA B receptor proteins, GABA B R1 and GABA B R2, have been cloned from mammalian nervous systems, and both exist in several alternatively spliced forms (Jones et al. 1998; Billinton et al. 2001; Lopez-Bendito et al. 2002) . The same two GABA B receptor subtypes and an additional GABA B R3 protein have also been isolated from Drosophila (Mezler et al. 2001) . In both mammalian and Drosophila systems the functional receptor comprises a heterodimer with the GABA B R1 and R2 subunits, but the role of R3 protein is unknown (Filippov et al. 2000; Margeta-Mitrovic et al. 2001; Mezler et al. 2001) . Using Western blot analysis we tested specific antibodies against the two essential GABA B receptor subtypes in spider brain and peripheral nerve tissues and we located both receptor proteins on the mechanosensilla using immunocytochemistry. To learn how the GABA B receptor immunoreactivity correlated with the synaptic sites and whether these receptors were present in the efferent fibers we performed double labeling experiments using a monoclonal antibody against synapsin that has previously been shown to specifically label the synaptic vesicles on the fine efferent fibers on the spider sensilla (Fabian-Fine et al. 1999a,b) . We also tested if specific GABA B receptor agonists modulate the voltage-activated currents and the excitability of identified peripheral mechanosensory neurons. by overnight incubation with the primary antibody in blocking buffer at 4 C. Primary antibodies were guinea pig anti-GABA B R1 (Chemicon International, Temecula, CA, AB1531, 1:2,500 dilution), guinea pig anti-GABA B R2 (Chemicon, AB5394, 1:500 dilution) and rabbit anti-GABA B R2 (Chemicon, AB5848, 1:500 dilution). The blot was then washed for 30 minutes in Tris buffer saline with 1% Tween 20, followed by incubation in peroxidase conjugated anti-guinea pig (Jackson ImmunoResearch Laboratories, West Growe, PA, 1:10,000 or 1:1,500 dilution) or anti-rabbit secondary antibody (Jackson, 1:5,000 dilution). Immunoreactive protein bands were visualized using an ECL plus chemiluminescent kit (Amersham Biosciences, Montreal, Quebec) according to the manufacturer's instructions.
Immunocytochemistry
A piece of cuticle from the anterior patella containing the lyriform VS-3 slit sense organ (nomenclature according to Barth and Libera 1970) was dissected free from the surrounding tissue.
The tissue was fixed with 4% paraformaldehyde (Fisher) in PBS for 20 min followed by several rinses in PBS. Tissue was then penetrated with 1% Triton X-100 in PBS for one hour followed by incubation in the blocking solution (5% normal goat serum, 1% bovine serum albumin Fraction V (Gibco, Burlington, Ontario), 3% skim milk powder and 0.6% Triton X-100 in PBS) for 2 hours.
The primary antibodies were dissolved in fresh blocking solution and the tissue was incubated in this solution overnight at 4 C. The same primary antibodies as in the Western blot experiments were used in the following concentrations: guinea pig anti-GABA B R1 (1:2,500), guinea pig anti-GABA B R2 (1:1,000) and rabbit anti-GABA B R2 (1:5,000 to 1:500). Monoclonal mouse anti-synapsin (SYNORF1, Dr. E. Buchner Universität Würzburg, Germany, Klagges et al. 1996) was used in 1:100 dilution. Tissue was then washed four times in 0.6% Triton X-100 in PBS followed by overnight incubation in the secondary antibodies in blocking solution at 4 C. The secondary antibodies were goat anti-guinea pig CY-3 (1:1,000) for the guinea pig anti-GABA B R1 and anti-GABA B R2 (Jackson Laboratories, 106-165-006), goat anti-rabbit AlexaFluor 488 10 g/ml (Molecular Probes, Eugene OR, A-11034) for the rabbit anti-GABA B R2, and goat anti-mouse Alexa Fluor 488 10 g/ml (Molecular Probes, A-11029) for anti-synapsin. Tissue was then washed four times in 0.6% Triton X-100 in PBS followed by five washes in PBS. The leg hypodermis were then carefully removed from the cuticle with the sensilla attached and placed on a microscope slide and mounted in a media containing Mowiol dissolved in 0.2 M Tris buffer enriched with 2.5% DABCO (1,4-diazabicyclo (2,2,2) octane) to reduce fading. For controls, one or both of the primary antibodies were omitted and/or the primary antisera were substituted with normal sera of the same species at the same dilution. For the monoclonal mouse antibody, mouse ascites fluid served as a control. For double labeling experiments the two primary and two secondary antibodies were used simultaneously.
The preparations were examined under epifluorescence optics with an Axiovert 100 inverted microscope (Carl Zeiss Oberkochen, Germany) and/or under a laser scanning confocal microscope (LSM 510, Carl Zeiss) with an argon-krypton laser for Alexa Fluor 488 (488 nm) and a helium-neon laser for CY-3 (543 nm). Digital images of the immunoreactive structures were captured and analyzed. The final images were enhanced in Adobe Photoshop 7.
Electrophysiology
Similar dissection of the anterior leg patella was performed as for the immunocytochemistry.
The hypodermis membrane with the VS-3 slit sense organ was detached from the cuticle and attached to a coverslip coated with 1 mg/ml poly-L-lysine (Sigma P5899) and then placed in a recording chamber as described previously in detail (Sekizawa et al. 1999) . The preparation was superfused continuously with spider saline (in mM: 223 NaCl, 6.8 KCl, 8 CaCl 2 , 5.1 MgCl 2 , 5 sucrose, and 10 HEPES, pH 7.8 (Höger et al. 1997 )) using a BPS-4 solution exchange system and PR10 pressure regulator (ALA Scientific, New York, NY). The drugs were injected either using the solution exchange system or manually with a syringe and a needle.
Intracellular recordings were performed from the somata of the VS-3 neurons using the discontinuous single-electrode current-and voltage-clamp methods (Finkel and Redman 1984) with a SEC-10 L amplifier (NPI Electronic, Tamm, Germany). The conditions for successful singleelectrode voltage-and current-clamp have been described previously (Torkkeli and French 1994), and the same methods have been used in VS-3 neurons to study voltage-activated currents (Sekizawa et al. 1999 (Sekizawa et al. , 2000 Torkkeli et al. 2001) . A horizontal puller (P-2000, Sutter Instrument, Novato, CA) was used to pull microelectrodes from borosilicate glass (1 mm OD and 0.5 mm ID).
Electrodes were filled with 3 M KCl or CsCl (see below) and their resistances were 40-80 M in solution. Switching frequencies of 20-25 kHz and a duty cycle of 1/4 (current passing/voltage recording) were used in all experiments. The neurons were located and observed under bright-field optics (Axioskop 2FS, Carl Zeiss).
They were impaled by high frequency oscillation ("buzzing") followed by 15 min stabilizing period before recordings. All experiments were controlled by an IBM compatible computer with custom written software (courtesy of Dr. A. S. French, Dalhousie University, Halifax, NS). Current or voltage stimuli were provided by the computer via a 12-bit D/A converter. The membrane potential recording was low-pass filtered at 33.3 kHz and the current signal was filtered at 3.3 kHz by the voltage-clamp amplifier.
For Ca 2+ current and Ca 2+ spike recordings the voltage activated Na + currents were blocked with 1 M tetrodotoxin (TTX) and K + currents with 25 mM tetraethylammonium chloride (TEA) and 25 mM 4-aminopyridine (4-AP). In most experiments Ba 2+ was used as the current carrier by replacing the extracellular Ca 2+ with the same concentration (8 mM) of Ba 2+ . In addition, the electrode filling solution in these experiments was 3 M CsCl. For K + current recordings 1 M TTX was used to block the Na + currents and 100 M Ni 2+ to block the Ca 2+ currents. The Ni 2+ application also caused inhibition of any intrinsic synaptic effects. GABA B receptor agonists were aliquoted and kept frozen until shortly before the experiment.
The following pharmacological agents and solutions were used: SKF97541 hydrochloride (3-aminopropylmethylphosphonic acid hydrochloride) (Sigma, A196) and 3-aminopropylphosphonic acid (3-APA) (Sigma, A7162) were initially dissolved in distilled water. (±)-Baclofen (Sigma, B5399) was initially dissolved in concentrated HCl. The total volume of the recording chamber was 500 l and the concentrations of the pharmacological agents shown in the Results section indicate the final concentrations in the chamber.
Statistical analysis was performed by comparing differences between means using two sided unpaired t-test with Prophet 6.0 software (AbTech Corporation, Charlottesville, VA).
RESULTS

Western blot analysis
Western blot analysis was used to test the specificity of commercially available anti-GABA B receptor antibodies on spider brain and peripheral nervous tissues. The peripheral tissue was obtained from the hypodermis in the leg femur and patella. The anti-GABA B R1 antibody produced a discrete darkly stained band at approximately 130 kDa in both tissues (Fig.1 ). This antibody is directed against two splice variants of the GABA B R1 receptor, and our findings are consistent with the 130 kDa molecular weight of the GABA B R1A splice variant. The guinea pig anti-GABA B R2 antibody produced a clear band at 105 kDa in both homogenates, corresponding closely to the values given in literature (e.g. Bowery et al. 2002) . This antibody required a relatively high protein concentration to produce specific staining and since we were not able to obtain large amounts of the peripheral tissue we also increased the secondary antibody concentration for the hypodermis homogenate. This resulted in the additional less discrete bands in the hypodermis homogenate probably representing unspecific staining. The rabbit anti-GABA B R2 antibody produced a clear band at 105 kDa in brain tissue, corresponding exactly to the manufacturer's description. We did not test this antibody on peripheral tissue because of the negative results with immunocytochemistry (see below).
Immunocytochemistry
Whole-mount preparations of pieces of hypodermis from spider patella were used for immunostaining with the same anti-GABA B receptor antibodies that were used in the Western blot experiments. In this preparation the VS-3 slit sensilla, one of the lyriform slit sense organs that detect strains on the spider cuticle ( Fig. 2A) , and numerous other sensilla remain attached to a hypodermis membrane. The VS-3 neurons expressed strong immunoreactivity against the guinea pig anti-GABA B R1 and R2 antibodies but the efferent neurons were not labeled and therefore not visible in the fluorescent images (Figs. 2B and C). The anti-GABA B R1 immunoreactive punctae were not limited to the neurons, but were also present in tissues surrounding the neurons, including glial cells. The staining pattern of the anti-GABA B R2 antibody was more specific: Clusters of immunoreactive punctae were seen in the distal halves of all of the VS-3 neurons but the proximal parts were not stained. The glial cells surrounding the neurons were not immunoreactive to this antibody. Intense immunoreactivity against both anti-GABA B receptor antibodies was also found in the small sensory neurons that innervate the trichobothrial (filiform) hairs, that are used for measuring air movements, and on larger groups of neurons that form the proprioceptive joint receptors. Because of the small size of most of these neurons the subcellular localization of staining in the cell bodies was difficult to determine, but it was also present on the axonal parts. Punctate staining was not seen in the control preparations ( Fig. 2D ), but fluorescing spots were often present in the peripheral regions of the cell bodies. The intensity of these spots was distinctly different to that produced by the fluorochromes that were used in this study and they have previously been shown to be caused by lipofuscin granules that appear in the neurons of older spiders (Fabian and Seyfarth 1997). The rabbit anti-GABA B R2 antibody produced no labeling in the spider tissue at concentrations from 1:5,000 to 1:500. To our knowledge this antibody has previously only been used for immunoblotting.
In order to learn if GABA B receptor labeling was postsynaptic to synaptic vesicles on the efferent fibers we performed double labeling experiments separately with both the guinea pig anti-GABA B receptor antibodies plus a monoclonal antibody against Drosophila synapsin (Klagges et al. 1996) . Previous work using fluorescence staining and epifluorescence optics as well as electron microscopical immunogold labeling has shown that the same synapsin antibody specifically labels synaptic vesicles in the efferent neurons forming contacts with mechanosensory neurons in the spider leg with no staining in the sensory neurons or the glial cells (Fabian-Fine et al. 1999a,b) . The specificity of this antibody in the spider tissue was also demonstrated in Western blot analysis labeled parts in the sensory neurons were in close contact with the anti-synapsin labeled elements.
However, this antibody also labeled elements that were not in contact with the anti-synapsin immunoreactive sites (Figs. 3C and F).
Anti-GABA B R2 labeling coincided with anti-synapsin labeling in the distal parts of the VS-3 neuron cell bodies and dendrites (Figs. 4C and F), but there was very little anti-GABA B R2 staining on the axons or proximal parts of the VS-3 neurons that were covered with anti-synapsin labeled fine efferent fibers ( Fig. 4B and E). Groups of three neurons innervating the tactile hairs and spines had similar staining patterns to the VS-3 neurons, with clusters of anti-GABA B R2 immunoreactivity on the distal parts of the cell bodies, and the largest cell body having more staining than the two smaller ones ( Fig. 4G ). Since the proximal parts of the sensory cell bodies were only faintly labeled with the anti-GABA B R2 antibody, and there was very little background staining on the sensory neurons, the shapes of the cell bodies are somewhat difficult to conceive from the projected confocal images.
Therefore, we increased artificially the brightness of the Fig. 4H to allow a clearer view to the whole neuron. The shape of the large neuron and the pattern of anti-GABA B R2 immunolabeling in this image are similar to the VS-3 neurons and very thin branches of anti-synapsin labeled fibers extend to these cell bodies ( Fig. 4H and I) .
Confocal 0.5 m sections through the different sensilla revealed that the anti-synapsin labeled efferent branches that extended onto the neurons innervating the slits or the tactile hairs and spines were not stained with anti-GABA B R1 or anti-GABA B R2 antibodies. In addition, those antisynapsin labeled fine fibers that were separated from the surrounding tissue did not show anti-GABA B -receptor immunoreactivity in the projected confocal images (e.g. Fig. 4F ). Similarly, the sensory neurons did not express any anti-synapsin immunoreactivity. The extensive immunoreactivity with anti-GABA B R1 antibody in the main leg nerve (Fig. 3D ) originates most probably from the sensory axons and the glial cells. Similar difference in the R1 and R2 subunit immunoreactivity has been demonstrated in the rodent nervous system (Yung et al. 1999; Ng and Yung 2001) . The anti-GABA B R1 also produced some staining in the hypodermis membrane, but this staining was significantly sparser to that seen in the sensory neurons and may be unspecific staining.
Modulation of voltage-activated currents by GABA B receptor agonists
Spider VS-3 neurons produce a large Ca 2+ current at low voltages (-40 to -20 mV). This LVA-I Ca produces Ca 2+ spikes when the voltage-activated K + and Na + currents are blocked (Sekizawa et al. 2000) . We tested the effects of the GABA B receptor agonists baclofen and SKF97541 on the LVA-I Ca and on the Ca 2+ spikes. The voltage-clamp recordings were performed using Ba 2+ as the current carrier instead of Ca 2+ . At 400 M concentration both GABA B receptor agonists significantly reduced the Ba 2+ current (I Ba ) and this reduction was reversible, although it often took a long time (10 min -1 hour) before complete reversal (Fig. 5A ). The I Ba reduction was largest at the peak of the Ca 2+ current at -40 mV to -30 mV (Fig. 5B ).
We performed current-clamp experiments on preparations where the Na + and K + currents were blocked and elicited Ca 2+ spikes with electrical stimulation to test whether they could be modulated by the GABA B receptor agonist SKF97541. Figure 6 shows an example of this type of recording. TTX blocked the Na + -current completely but the neuron fired large action potentials in response to current stimulus when the K + currents (I K ) were also blocked. In intracellular recordings with sharp microelectrodes complete inhibition of outward K + currents is not possible, since the intracellular K + can not be replaced. The I K inhibition developed slowly and some outward I K may still have been present when the neurons were depolarized strongly, probably contributing to the repolarization of Ca 2+ spike. The normal trend of the Ca 2+ spike development was a rapid increase in spike amplitude and gradual increase in its duration probably reflecting the effectiveness of K + current block. When SKF97541 was added to the bath solution, a significant decrease in Ca 2+ spike duration was recorded in three experiments and in two of these experiments the spike amplitude was also slightly reduced. These effects were transient and fully reversible even without wash in normal spider saline. GABA B receptors on postsynaptic membranes often activate an inwardly rectifying K + conductance. To learn if this occurs in the VS-3 neurons, we tested GABA B receptor agonist effects on preparations where Ca 2+ currents were blocked by 100 M Ni 2+ , which also blocks any possible intrinsic synaptic effects. Neither baclofen nor SKF97541 (400-800 M ) produced inward currents at the voltage ranges expected (-140 to -60 mV) in 15 experiments. We also investigated whether SKF97541 modulates the voltage-activated outward K + currents (I K ) that has been previously investigated in the VS-3 neurons (Sekizawa et al. 1999) . A small, but a distinct increase in the I K amplitude was seen in all three experiments (Fig. 7) . This increase occurred immediately after agonist application and reversed relatively quickly, in less than 15 min without wash with normal saline. The time scale of this effect was similar to the change in the Ca 2+ spike duration (Fig. 6) .
GABA B receptor mediated long term effects on VS-3 neurons
Long term synaptic effects on VS-3 neurons can be investigated for several hours when intracellular sharp electrodes are used. We performed experiments using the following GABA B Table 1 . The membrane resistance or potential did not change in response to agonist application.
There were small but not statistically significant changes in the thresholds for firing action potentials or the actual numbers of action potentials that the cells fired in response to step current stimuli.
Experiments with baclofen and 3-APA produced similar results. These results suggest that the physiological effects of GABA B receptor activation in spider VS-3 neurons develop very slowly or may be more obvious when mechanical rather than electrical stimuli are applied.
A clear difference in the cell's response to step current stimuli was seen in 15 of 16 experiments. Fig. 8A shows a neuron that fired a brief burst of action potentials and Fig. 8B is an example of a neuron that fired a maximum of two action potentials in response to a step stimulus.
In both cases the stimulus induced depolarization was larger within 2-5 min after GABA B receptor agonist application and increased during washing periods of one to two hours. This effect did not reverse in any of the experiments. In five experiments the action potentials became smaller and fused (Fig. 8A) . The change in the stimulus induced depolarization was not correlated with changes in passive membrane resistance (Table 1) . In order to learn if this effect was mediated by Ca 2+ , we performed five similar experiments in which the I Ca was blocked by 100 M Ni 2+ . In three of these experiments a significantly smaller increase in the stimulus evoked depolarization developed more slowly than in the control experiments, in one experiment the depolarization was actually reduced and in one there was no change.
DISCUSSION
Anti-GABA B receptor immunoreactivity in the spider brain and mechanosensilla
Functional metabotropic GABA B receptors are formed from heterodimers of two proteins, GABA B R1 and R2 (Jones et al. 1998; Kaupmann et al. 1998; Mezler et al. 2001; Bowery et al. 2002) . In this report we demonstrate that both of these receptor proteins are abundantly present in the spider central and peripheral nervous tissues. The commercially available guinea pig anti-GABA B R1 antibody was developed against a common sequence in two GABA B receptor isomers and produced a 130 kDa protein band corresponding to the GABA B R1A isomer that is also prevalent antibodies that we tested in the spider brain homogenate produced an expected 105 kDa band in the Western blot analysis and the guinea pig antibody also produced a similar band in the peripheral tissue. The rabbit anti-GABA B R2 antibody, which has previously only been tested in immunoblotting, produced no labeling by immunocytochemistry, but the guinea pig antibody revealed a very specific staining pattern in spider mechanosensilla.
In the spider leg hypodermis the anti-GABA B R1 immunoreactivity was more widespread than anti-GABA B R2 labeling. The former antibody stained all parts of the neurons and some of the glial cells while the latter staining was restricted to the sensory neurons. Some of the anti-GABA B R1 staining may represent nonfunctional precursor molecules. Similar findings have been made with the same antibodies in human and rodent CNS and this has lead to speculation that additional receptor subtypes may exist that could also dimerize with GABA B R1 to form functional receptors (Yung et al. 1999; Billinton et al. 2000; Ng and Yung 2001) . However, significant amount of the anti-GABA B R1 staining did not coincide with the anti-synapsin staining suggesting that this receptor subtype in the spider peripheral tissue is expressed extrasynaptically as well as synaptically. Most confocal sections through the spider sensory neurons showed immunoreactivity with both anti-GABA B receptor antibodies, suggesting that the receptor proteins are present intracellularly as well as in the plasma membrane. Previous electron microscopical studies from the rat cerebellum have indicated that while the majority of both receptor proteins are found in the plasma membrane they are also present intracellularly (Ige et al. 2000) suggesting that nonfunctional subunits that have not yet been transported to their final locations were also stained. Since the anti-GABA B receptor antibodies that produced immunostaining in spider tissue were both made in the same host, we could not perform double labeling experiments to test how these proteins are co-localized. However, both proteins were found in the sensory neurons in locations that were postsynaptic to the anti-synapsin stained efferent neurons. Clustering of GABA B R2 on the distal parts of the cell bodies, where there was also a large amount of anti-GABA B R1 staining, suggests that these receptors may play a critical role in modulating the sensory input close to its site of detection.
GABA B receptor effector mechanisms in the VS-3 neurons
The GABA B receptor agonists baclofen and SKF97541 both reduced the amplitude of LVA-I Ca in the spider VS-3 neurons. In mammalian nervous system the GABA B receptor mediated effects on Ca 2+ conductances usually involve presynaptic P/Q-and N-type channels (Chen and van der Pol 1998; Bowery et al. 2002) . However, in thalamocortical neurons GABA B receptors elicit low threshold Ca 2+ potentials, which give rise to high frequency bursts of action potentials (Crunelli and Leresche 1991) and a low voltage-activated T-type current in a rat cultured dorsal root ganglion neurons is modulated by baclofen. In the latter case, low baclofen concentration enhanced the current but high concentration caused a reduction (Scott et al. 1990 ). The LVA-I Ca in spider VS-3 neurons does not produce high frequency firing and its physiological function is unknown. A previous investigation concluded that this current does not play any part in the spike generation or frequency modulation. However, it can increase the action potential amplitude and duration when K + currents are blocked, and produce spikes when the Na + channels are also inhibited (Sekizawa et al. 2000) . Clearly, the GABA B mediated reduction of LVA-I Ca would attenuate Ca 2+ influx and, since this effect is long lasting, it may have a significant effect on intracellular processes that are mediated by Ca 2+ .
The GABA B receptor agonist SKF97541 induced a transient small increase in the amplitude of the outwardly rectifying I K in the VS-3 neurons when the intrinsic synaptic activity was blocked by Ni 2+ . However, neither SKF97541 nor baclofen activated inward K + currents, as has been found in postsynaptic locations of many mammalian and invertebrate preparations. In cockroach motor neurons (Bai and Sattelle1995) receptor-mediated mechanism may be involved, but were not studied here. For example, they can stimulate phospholipase A, inhibit adelylate cyclase and regulate inositol phosphate hydrolysis (Misgeld et al. 1995) . In the mammalian spinal cord and brain, presynaptic GABA B receptor activation has also been shown to modulate glutamate, ACh and dopamine release (Towers et al. 2000; Balon et al. 2002; Li et al. 2002) . We found no evidence of presynaptic GABA B -receptors on the efferent neurons surrounding the sensory neurons that innervate the slits, tactile hairs or spines, indicating that GABA B receptors do not serve as autoreceptors on the GABAergic efferents and that functional receptors are present only on the sensory neurons. Since the majority of these receptors were strategically located on the distal parts of the sensory neurons, their most obvious function is in regulating the transduction of sensory signals. The normal locomotory activity of Cupiennius has been shown to be restricted to the dark period of the day and the responsiveness of the mechanosensilla is significantly lower during daytime than at night (Seyfarth 1980) . It is possible that the GABA B receptor mediated inhibition is responsible for the lower responsiveness during daytime. The two sensory neurons that innervate each slit in the spider lyriform sensilla have previously been shown to have different adaptation properties (Seyfarth and French 1994) . We found no differences in the GABA B receptor immunolableing or the GABA B agonist induced effects in the different neuron types suggesting that both types can be modulated by GABA B mediated mechanisms.
The clearest long term effects of GABA B receptor agonists that we detected in VS-3 neurons was the depolarization in response to a current stimulus. This could not be a direct consequence of either increased I K , or decreased I Ca . Since this effect was partially removed when Ca 2+ currents were blocked with Ni 2+ , it may have been produced by mechanisms initiated by reduced I Ca . We have not seen similar effects in response to the GABA B receptor activation reported previously in other preparations. However, all previous intracellular work has been done using whole-cell patch-clamp where the neurons are not viable for such a long time as with sharp electrode recordings. The increased stimulus induced depolarization was more clearly visible about 15 minutes after agonist application and continued to increase in recordings that lasted for up to two hours. Physiologically, this effect would make it more difficult for the neurons to respond to high frequency stimuli since the action potentials would not be able to repolarize and therefore new spikes would not be fired.
Future research into the possible changes in the neuron's frequency sensitivity in response to GABA B receptor activation would provide clarification to this question In conclusion, our findings suggest that functional GABA B receptors are abundantly present in spider brain and peripheral sensilla. Immunocytochemical localization of these receptors has not been described in any invertebrate tissue, although it is known that they exist in the CNS. In addition, while GABA B receptors have been shown to modulate mammalian mechanoreceptors and nociceptors, they have not been described in locations that are close to the sensory endings. Our findings suggest that mechanosensory input in spider peripheral sensilla may be finely tuned by GABA B receptor activation on the most distal parts of the sensory afferents. This would probably change the neuron's ability to detect different stimulus frequencies and amplitudes, and could cause a slow, sustained inhibition when the neurons are subjected to a repeated stimulus or when a change is required by behavioral circumstances. autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations. Neuropharmacology 38: 1707-1721, 1999. E m = resting potential; Current Threshold = current stimulus needed to elicit an action potential;
Staubli
Voltage Threshold = membrane potential increase needed to elicit an action potential. SKF97541
concentrations used for these experiments were from 200-800 M. When 80 M SKF97541 was added to the bath solution, a transient reduction of the Ca 2+ spike duration and amplitude was seen. In this experiment the spike amplitude was 90 mV and duration 37 27 ms 1 min after SKF97541 application. The Ca 2+ spike then gradually returned to its original shape. In this experiment the spike amplitude 10 minutes after SKF97541 application was 100 mV and duration 42 ms. B. A neuron that fired two action potentials in response to a 1.5 nA current pulse (continuous line).
Figure legends
Two minutes after application of 800 M SKF97541 a slightly larger depolarization was produced (dashed line) in response to similar stimulus and no change in the action potential amplitude or duration. The evoked depolarization continued to increase when the preparation was washed for 55 min with normal saline (dotted line). 
